title: [Phase II trial of concomitant cyclic radio-chemotherapy combination (ARCCC) in unoperable non-small cell lung cancer (CBNPCI)].
authors.affiliation: Clinique Hartmann, Neuilly-Sur-Seine, France.
authors.forename: J M
authors.initials: JM
authors.lastname: Vannetzel
authors.forename: J L
authors.initials: JL
authors.lastname: Rebischung
authors.forename: A
authors.initials: A
authors.lastname: Chapelier
authors.forename: P
authors.initials: P
authors.lastname: Dartevelle
authors.forename: J
authors.initials: J
authors.lastname: Sauvaget
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D002289:Carcinoma, Non-Small-Cell Lung / Q000188:drug therapy* / Q000532:radiotherapy; D002945:Cisplatin / Q000627:therapeutic use*; D003131:Combined Modality Therapy; D005472:Fluorouracil / Q000627:therapeutic use*; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy* / Q000532:radiotherapy; D011829:Radiation Dosage; D014751:Vindesine / Q000627:therapeutic use*
chemical_list: D002945:Cisplatin; D014751:Vindesine; D005472:Fluorouracil
vernacular_title: Essai de phase II par association radio-chimiothérapie concomitante cyclique (ARCCC) dans les cancers bronchiques non à petites cellules inopérables (CBNPCI).